Despite major advances in cardiopulmonary bypass technology, surgical
techniques, and anesthesia management, central nervous system complica
tions remain a common problem after cardiopulmonary bypass. The etiolo
gy of neuropsychologic dysfunction after cardiopulmonary bypass remain
s unresolved and is probably multifactorial. Demographic predictors of
cognitive decline include age and years of education; perioperative f
actors including number of cerebral emboli, temperature, mean arterial
pressure, and jugular bulb oxygen saturation have varying predictive
power. Recent data suggest a genetic predisposition for cognitive decl
ine after cardiac surgery in patients possessing the apolipoprotein E
epsilon-4 allele, known to be associated with late-onset and sporadic
forms of Alzheimer's disease. Predicting patients at risk for cognitiv
e decline allows the possibility of many important interventions. Pred
ictive power and weapons to reduce cellular injury associated with neu
rologic insults lend hope of a future ability to markedly decrease the
impact of cardiopulmonary bypass on short-term and long-term neurolog
ic, cognitive, and quality-of-life outcomes.